May 22 (Reuters) - Lantheus Holdings is weighing a potential sale after getting a takeover offer from private-equity backed ...
Lantheus Holdings (LNTH) quickly rose 7.4% on a report that it's evaluating a sale after receiving a takeover offer from Curium that values the radiopharma firm at about $7 billion. Lantheus (LNTH) ...
The acquisition of Nucleis will: Enhance Curium's PET manufacturing capacity and radiopharmaceutical distribution network of 32 PET sites in Western Europe Improve reliability and accessibility of ...
The recapitalization will accelerate Curium’s strategy to launch innovative, life-changing diagnostic and therapeutic solutions for cancer patients around the world BOSTON, Nov. 20, 2025 (GLOBE ...
PETTEN, The Netherlands, May 21, 2025 (GLOBE NEWSWIRE) -- NRG PALLAS and Curium have extended their collaboration to produce molybdenum-99 through a new multi-year agreement. Molybdenum-99, which ...
PARIS, May 29, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that it has signed a long-term agreement to extend its current partnership with NRG I PALLAS for new ...
Curium Pharma, the CapVest Partners-backed nuclear medicine imaging company, is poised to field first round bids early next week, people with knowledge of the matter told PE Hub. A process formally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results